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Abstract 
Background: Little is known regarding risk factors for lymphatic filariasis (LF) in Central Africa. To expand on what is 
known, we studied the epidemiology of LF in two endemic villages in the Democratic Republic of the Congo.
Methods: Dependent variables were Wuchereria bancrofti antigenaemia detected with filarial test strips (FTS) and 
microfilaraemia detected by night blood smears. The following factors were investigated: sex, age, the use of bednets, 
the use of latrines, hunting, fishing and agricultural activities, history of treatment with anthelmintic drugs, overnight 
stays in the bush, population density, the number of household members, and distance to rivers. Mixed multivariate 
logistic regression models were used.
Results: Two hundred and fifty nine out of 820 (31.6%) of subjects aged ≥ 5 years had W. bancrofti antigenaemia and 
11.8% (97/820) had microfilaraemia. Multivariable analysis of risk factors for antigenaemia demonstrated increased risk 
for males (aOR = 1.75, 95% CI: 1.20–2.53, P = 0.003), for older individuals (aOR = 9.12 in those aged > 35 years, 95% CI: 
4.47–18.61, P < 0.001), for people not using bednets (aOR = 1.57, 95% CI: 1.06–2.33, P = 0.023), for farmers (aOR = 2.21, 
95% CI: 1.25–3.90, P = 0.006), and for those who live close to a river (aOR = 2.78, 95% CI: 1.14–6.74, P = 0.024). Signifi-
cant risk factors for microfilaraemia included age, male gender, overnight stay in the bush, and residence close to a 
river (aOR = 1.86, 2.01, 2.73; P = 0.011, 0.010, 0.041; for the three latter variables, respectively). People who reported 
having taken levamisole (n = 117) during the prior year had a significantly decreased risk of having filarial antigenae-
mia (aOR = 0.40, 95% CI: 0.21–0.76, P = 0.005).
Conclusions: Age, sex, not using bednets, and occupation-dependent exposure to mosquitoes were important risk 
factors for infection with W. bancrofti in this study. The association with levamisole use suggests that the drug may 
have prevented filarial infections. Other results suggest that transmission often occurs outside of the village. This 
study provides interesting clues regarding the epidemiology of LF in Central Africa.
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Background
Lymphatic filariasis (LF), a major neglected tropical dis-
ease (NTD), is a mosquito-borne parasitic infection 
caused by Wuchereria bancrofti, Brugia malayi and B. 
timori. The Global Programme to Eliminate Lymphatic 
Filariasis (GPELF) was launched in 2000 with the goal 
of eliminating LF as a public health problem by 2020. To 
date, more than 7 billion treatments have been distrib-
uted during annual mass drug administration (MDA) 
campaigns [1]. MDA is no longer required in 21 of 72 
endemic countries, and 11 of these have been validated 
by the World Health Organization (WHO) as having 
eliminated LF as a public health problem [1].
LF elimination programmes are not as advanced in 
Central Africa as in other regions, although there have 
been improvements in MDA coverage in recent years. 
Initially, the delay observed in Central Africa was due to 
(i) a lack of accurate epidemiological and geographical 
information on LF distribution [2–5]; (ii) concern about 
the potential risk of serious adverse events after ivermec-
tin treatment in areas where Loa loa is co-endemic [6]; 
and (iii) insecurity and political instability in some coun-
tries. In addition, large-scale mapping surveys conducted 
in recent years revealed that LF distribution in this region 
is highly focal [5] and that the total population requiring 
MDA for LF was lower than expected [7]. Furthermore, 
the circulating filarial antigen (CFA) detection test used 
to map LF sometimes produces false positive results in 
individuals with high Loa loa microfilarial densities [8]. 
Thus, mapping for LF based on CFA testing overesti-
mated the extent of LF in some areas (e.g. in Cameroon) 
[9].
In a previous paper, we investigated risk factors associ-
ated with W. bancrofti infection in a village in the Repub-
lic of Congo where baseline infection level was moderate 
(CFA prevalence: 17%) [5]. That study showed that over-
night stays in the bush for hunting or fishing activity was 
a significant risk factor for filarial infection. The present 
study was conducted to assess risk factors in villages 
located in the western part of the Democratic Republic of 
the Congo (DRC) where LF prevalence was much higher 
than in the Republic of Congo study. This additional 
study is important, because it adds significant new infor-
mation on individual risk factors for LF in Central Africa.
Methods
Context of the study
This study was carried out with baseline data collected 
in June 2014 during a community-based study to assess 
the impact of biannual mass administration of albenda-
zole on LF [10]. In July 2013, community surveys were 
performed in 13 villages of the Kwilu Province. The sur-
vey area was delineated by Bandundu-ville in the west, 
Beno in the east, and the Kasaï and Kwilu rivers in the 
north, until 20 km south. Filarial antigenaemia rates were 
strongly heterogeneous, and Mbumkimi and Misay were 
the only villages where the prevalence of antigenaemia 
reached 40%.
Study site
The study was conducted in two villages, Mbumkimi and 
Misay (3°31′41″S, 17°37′44″E and 3°30′44″S, 17°37′29″E, 
respectively) in the Bagata territory of Kwilu Province, 
about 50  km east of the capital city of the province, 
Bandundu-ville. The villages are located less than 2 km 
apart, and both are located on the northern bank of the 
Kwilu River. The river is approximately 200 m wide near 
the study villages. In addition, a stream several meters 
wide, called Nsitim, flows into the Kwilu River approxi-
mately 300 m east of Mbumkimi (Fig. 1). The vegetation 
is comprised of forest savanna with gallery forests along 
the rivers. There are two seasons: a dry season from May 
to October, and a rainy season from November to April. 
The populations of Mbumkimi and Misay, as assessed 
by a census conducted in May 2014, were 843 and 423, 
respectively. The main occupational activities in the study 
villages are agriculture and fishing.
Survey methods
In June-July 2014, adults and children ≥ 5  years of age 
were invited to participate in the community survey. Par-
ticipants who signed a written consent form (assent plus 
written consent from at least one parent was required for 
children < 18 years of age) were screened for CFA using 
the Alere Filariasis Test Strip (FTS, Scarborough, ME, 
USA) [11]. Capillary blood was collected by finger prick 
using a sterile disposable lancet in a hematocrit tube. The 
blood (70 μl) was then transferred on the sample applica-
tion pad of the strip following the manufacturer’s instruc-
tions. A single trained person read all of the tests at 
10 min, and results were recorded as negative or positive. 
Participants with a positive FTS result were re-sampled 
between 10:00 PM and midnight to prepare two thick 
blood smears (70 µl) for detection of microfilariae (mf). 
Slides were dehaemoglobinized, stained with Giemsa 
within 24  h, and read by two independent microsco-
pists. The arithmetic mean count from the two slides was 
recorded as mf density (expressed in mf/70 μl). All indi-
viduals with a negative FTS result were considered to be 
amicrofilaraemic.
Questionnaire
A standardized questionnaire was used to collect demo-
graphic information (full name, age, sex), information 
on the peridomestic environment, and the individual’s 
activities outside the immediate village environment. 
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Questions on the peridomestic environment asked about 
access to latrines (yes/no) and use of bednets during 
the previous night (yes/no) as a proxy for regular usage 
of bednets. Other questions included: hunting (yes/no), 
fishing (yes/no), agricultural activities (in three catego-
ries: none; yes, in fields located on the same side of the 
Kwilu River; and yes, in fields located across the Kwilu 
River). Participants were also asked if they occasionally 
stayed overnight in the bush (no/yes). Participants were 
also asked whether they had taken anthelmintic drugs 
within the previous year (yes/no); if the answer was yes, 
the name of the drug was recorded.
Environmental assessment
Houses were georeferenced using GPS on smartphones. 
Geospatial data were collected in World Geodetic Sys-
tem (WGS) 1984 geographical coordinates and projected 
using the WGS 1984 World Mercator coordinate refer-
ence system. The accuracy of georeferencing was 4 m. 
Roads and rivers were also mapped.
Statistical analysis
Dependent variables
Analyses were conducted using CFA and microfilaraemia 
(mf) as dependent variables.
Explanatory variables
The following individual factors were coded as categori-
cal variables: village of residence (Mbumkimi or Misay), 
sex (M/F), use of latrines (yes/no), use of bednet (yes/no), 
hunting (yes/no), fishing (yes/no), occasional overnight 
stays in the bush (yes/no), agricultural activities (no; yes, 
in fields located on the same side; yes, in fields located 
across the Kwilu River), and history of anthelmintic 
treatment (yes/no). Age was categorized into 4 balanced 
classes: 5–10; 11–20; 21–40; and > 40 years. The number 
of members for each household was included as a quan-
titative variable. Regarding the environmental variables, 
distances (as the crow flies) between each house and each 
river (Kwilu and Nsitim rivers) were calculated catego-
rized using ArcGIS v.10.4 (ESRI, Redlands, CA, USA) as 
Ns
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Fig. 1 Study area of Misay and Mbumkimi. Each point indicates the location of a household. The red star indicates the location of the villages
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follows: 0–300; 300–400; and > 400 m. The GPS location 
was unavailable for 24 households, corresponding to 60 
individuals (7.3% of the study population), and these were 
considered to be missing data. Lastly, we defined the 
population density (in the confines around the outermost 
houses) using ArcGIS (inhabitants per  km2), and then, 
each residence was categorized into three balanced levels 
(low, intermediate, and high population density).
Risk factors associated with filarial infection
Bivariate analyses were conducted using Chi-square tests 
to evaluate differences between FTS positive and nega-
tive individuals and between individuals with and with-
out microfilaraemia. A multivariable analysis including 
all variables associated with CFA or mf at P < 0.25 by 
bivariate analysis was performed using a descending pro-
cedure. We used mixed multivariable logistic regression 
models with household as random effect on the inter-
cept. From the final models, we estimated the population 
attributable fractions (PAF) for each independent vari-
able by the presence of CFA and mf (i.e. we estimated the 
proportional reduction in the prevalence of CFA and mf 
if the risk factor was absent). This was performed using 
the punaf package in STATA software. All analyses were 
performed using the STATA v.12.1 software (StatCorps, 
LP, College Station, TX, USA).
Results
Study population
A total of 1290 people, including 1033 aged ≥ 5  years, 
were recorded in the two villages during the census. 
About 100 individuals could not be registered (e.g. due to 
refusal), and thus the total population in the two villages 
was about 1400. Of the 1290 people recorded, 820 sub-
jects [including 383 males (46.7%) living in 255 house-
holds] were tested for filarial antigenaemia by FTS. Their 
median age was 20 years (range: 5–79 years, interquartile 
range: 10–35 years). Parasitological results are shown in 
Table 1 and univariate analyses of risk factors for W. ban-
crofti infection are shown in Table 2. Among participants 
who reported having taken anthelmintic drugs during the 
past year (n = 223), 117 had taken levamisole, 53 meben-
dazole, 52 albendazole, and 1 pyrantel.
Filarial antigenaemia
The proportion of subjects with CFA in the study popu-
lation was 31.6% (259/820). The prevalence was slightly 
higher in males than in females (34.2 vs 29.3%, respec-
tively; Pearson’s Chi-square test: χ2 = 2.28, df = 1, 
P = 0.131) and increased linearly with age for both sexes 
leveling off at 40–50 years of age (Fig. 2).
Microfilaraemia
Microfilaria were detected in night blood from 37% 
(97/259) of participants with positive FTS results. The 
W. bancrofti mf prevalence was 11.8% (97/820), with a 
higher value in males than in females (14.4 vs 9.6%; Pear-
son’s Chi-square test: χ2 = 4.41, df = 1, P = 0.036). Micro-
filaraemia prevalence increased linearly with age between 
5 and 50  years in males, while a sharp increase in mf 
prevalence was observed in females after age 40 (Fig. 3).
Risk factors for filarial antigenaemia
In the final model (Table 3), the risk of filarial antigenae-
mia increased with age (adjusted odd ratio aOR = 9.12, 
95% confidence interval CI: 4.47–18.61, P < 0.001, in 
those aged > 35  years, when compared with individu-
als aged 5–10 years, P < 0.001). Males had a higher CFA 
prevalence than females (aOR = 1.75, 95% CI: 1.20–2.53, 
P = 0.003). People who (i) did not use bednets, (ii) per-
formed agricultural activities, (iii) had not taken anthel-
mintics during the past year, and (iv) lived near the Nsitim 
River (Fig.  4, kernel interpolation), had a significantly 
increased risk for CFA (Table  3). Random household 
effect, representing all unmeasured contextual effects 
common within a household (e.g. habits, genetic com-
ponent), was significant (likelihood-ratio Chi-bar-square 
test: χ2 = 6.78, df = 13, P = 0.005). Lastly, the calculation 
of the attributable parts of each variable (Table 4) indi-
cates that agricultural activities were responsible for the 
highest PAF value (30.5%, 95% CI: 7.4–47.9), and that the 
total PAF related to activities outside of the villages (e.g. 
agricultural activities plus staying overnight in the bush) 
was 36.0%. Similarly, the total PAF due to factors internal 
to the village (use of bednets plus proximity to the river) 
was 18.9%. Interestingly, not having taken anthelmintics 
was found to have an important impact (PAF = 25.7%, 
95% CI: 8.9–39.4). When models were run to consider 
the different drugs taken by the subject, only history of 
levamisole treatment was significantly associated with a 
decreased risk for CFA (aOR = 0.40, 95% CI: 0.21–0.76, 
P = 0.005) (Table 5). Among those taking levamisole, no 
drugs, mebendazole, and albendazole, 16.2, 34.8, 30.2, 
and 30.8% were FTS positive, respectively (Pearson’s Chi-
square test: χ2 = 15.64, df = 3, P = 0.002). Interestingly, a 
history of levamisole treatment was more common in the 
youngest age group (Pearson’s Chi-square test: χ2 = 50.84, 
df = 9, P < 0.0001). There was no interaction between the 
drug variable and age in an analysis that used anthelmin-
tic drugs as a binary variable (likelihood-ratio Chi-square 
test: χ2 = 5.71, df = 3, P = 0.769) or as a categorical vari-
able by name of drug (likelihood-ratio Chi-square test: 
χ2 = 1.24, df = 9, P = 0.743).
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Risk factors for W. bancrofti microfilaraemia
In the final model, age was a strong risk factor for micro-
filaraemia (aOR = 12.68, 95% CI: 4.22–38.07, for persons 
> 35  years of age) (Table  6). Male sex was linked to a 
higher prevalence of mf (aOR = 1.86, 95% CI: 1.15–3.01, 
P = 0.011). Persons who occasionally stayed overnight 
in the bush (aOR = 2.01, 95% CI: 1.18–3.42, P = 0.010), 
who had not taken anthelmintics (aOR = 2.50, 95% CI: 
1.33–4.72, P = 0.005), and who lived near the Nsitim 
River (aOR = 2.73, 95% CI: 1.04–7.11, P = 0.046) had 
an increased risk for mf. Household effect was not sig-
nificant (Likelihood-ratio Chi-bar-square test: χ2 = 0.41, 
df = 10, P = 0.260). Lastly, the PAF related to previous 
anthelmintic treatment suggested that if all people in the 
study had taken levamisole within the past year, the mf 
prevalence in the study villages might have been 43.3% 
lower than what was observed (Table 4). As seen in the 
CFA analyses, only levamisole was significantly associ-
ated with a decreased risk for mf (aOR = 0.41, 95% CI: 
0.17–0.99, P = 0.048) (Table 5). However, when analyses 
were restricted to the 259 FTS positive individuals, only 
overnight stays in the bush tended to be associated with 
mf (aOR = 1.69, 95% CI: 0.94–3.03, P = 0.078). Conse-
quently, levamisole (or other anthelmintic treatment) 
was not significantly associated with mf in individuals 
infected with W. bancrofti.
Discussion
Little is known regarding the risk factors associated with 
LF in Central Africa and its micro-epidemiology. Results 
from this study confirm some findings from a similar 
study that was conducted in the village of Seke Pembe, 
in the Republic of Congo [5], namely that the risk of 
infection with W. bancrofti increased with age, and males 
had higher infection prevalences than females, independ-
ent of the other variables. These profiles are commonly 
seen in other areas around the world. The use of bednets 
was a protective factor against LF infection, and anthel-
mintic treatment during the past year appeared to be 
strongly protective, especially regarding mf prevalence. 
There was no difference in bednet use for individuals who 
had or had not taken anthelmintics (Pearson’s Chi-square 
test: χ2 = 0.0016, df = 1, P = 0.968), and there was no 
interaction between these two variables (likelihood-ratio 
Chi-square test: χ2 = 0.48, df = 1, P = 0.489); this suggests 
that bednets and anthelmintic treatment had independ-
ent protective effects.
The protective effect of anthelmintics appeared to be 
only significant for levamisole. Published studies of the 
effects of levamisole for W. bancrofti and Brugia malayi 
infections show that it temporarily reduces mf densities 
(ranging from 78.8 to 98.5%) [12–16]. However, while 
levamisole is known to have a transient microfilaricidal 
effect, none of these trials suggested that it has a macro-
filaricidal effect. Thus, the lower CFA prevalence in per-
sons who reported levamisole use was unexpected. It is 
possible that levamisole has previously unrecognized 
macrofilaricidal or prophylactic effects on W. bancrofti. 
This unexpected result should be investigated more thor-
oughly, because we cannot exclude possible confound-
ing factors at this time, and because this study was not 
specifically designed to assess the effect of anthelminthic 
drugs on the acquisition of filarial infection. We cannot 
exclude a possible similar protective effect of albendazole 
since relatively few people reported having taken alben-
dazole during the year prior to our survey.
Our study identified several activities as risk factors for 
CFA and microfilaraemia. Infection was more frequent 
in individuals who worked in agriculture. However, the 
risk of infection was not higher in persons who worked 
in fields located across the Kwilu River. This suggests that 
frequent river crossings did not increase workers’ expo-
sure to infective mosquitoes. This conclusion is consist-
ent with the finding that proximity of households to the 
Kwilu River was not significantly associated with a higher 
risk of infection. The PAF of risk for infection associated 
with agricultural activity was second only to anthelmintic 
intake, the latter of which might be considered to be an 
intervention rather than a risk factor. In addition, given 
the link between agricultural activity and LF test positiv-
ity, it would be of interest to try to elucidate the causal 
mechanism driving this relationship. These could identify 
possibly beneficial interventions for the population.
It is interesting to note that results from this study, 
which suggest a large amount of LF transmission 
occurs outside of the village, are consistent with results 
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of our prior study in Republic of Congo [5]. A history 
of frequent fishing was not associated with the pres-
ence of infection, with or without adjusting for age, 
sex or agricultural activity. This result may be because 
most fishing activities occur during the day and not in 
the evening when exposure to Anopheles mosquitoes is 
highest.
The population density around houses and the number 
of household members were not associated with infec-
tion risk. This result suggests that there was no dilution 
or concentration effect on transmission related to the 
domestic or peridomestic environment. This finding 
also suggests that transmission does not mainly occur 
in or near residences. Studies in east Africa reported 
that Anopheles densities decrease significantly beyond 
400 m from water sites [17, 18]. Similarly, a meta-analy-
sis showed that increasing distance away from breeding 
sites was associated with an 11% reduction in malaria 
risk per 100 m [19]. We have limited information on the 
mosquito fauna in the study area. Studies in and around 
Bandundu-ville detected abundant A. gambiae (s.l.) [20], 
especially complex member A. coluzzii (s.s.) [21]. How-
ever, A. funestus (s.l.), and to a lesser extent, A. moucheti 
(s.l.) and A. nili (s.l.) might also be significant vectors for 
LF in the study area [22].
It is interesting that proximity to the Nsitim River was 
a risk factor while proximity to the Kwilu River was not. 
The Kwilu is a large river (200 m wide), while the Nsitim 
River is a small stream that flows slowly in a dense gallery 
0
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Fig. 3 Age-profiles for W. bancrofti microfilarial prevalence. Males 
(solid line), females (dashed line). Bars indicate 95% confidence 
intervals
Table 3 Multivariable logistic regression analysis of risk factors for filarial antigenaemia in the total population. Likelihood-ratio test for 
random effect vs fixed effect model, final model (P = 0.005)
Abbreviations: Adj OR, adjusted odds ratio; AH, anthelmintic drug; CI, confidence interval; na, not available
Variable Category Full model Final model
Adj OR (95% CI) P Adj OR (95% CI) P
Age (ref: 5–10 years-old) 11–20 2.72 (1.42–5.20) 0.002 3.03 (1.59–5.75) 0.001
21–35 5.19 (2.53–10.65) <0.001 5.46 (2.68–11.12) 0.001
> 35 8.23 (4.05–16.73) <0.001 9.12 (4.47–18.61) <0.001
Sex (ref: female) Male 1.82 (1.25–2.66) 0.002 1.75 (1.20–2.53) 0.003
Village (ref: Mbumkimi) Misay 0.92 (0.54–1.56) 0.758
Bednets (ref: yes) No 1.46 (0.99–2.14) 0.056 1.57 (1.06–2.33) 0.023
Latrines (ref: no) Yes 0.88 (0.54–1.43) 0.609
Fishing (ref: no) Yes 1.27 (0.83–1.94) 0.277
Occasional stay in the bush (ref: no) Yes 1.35 (0.86–2.11) 0.186 1.45 (0.92–2.28) 0.105
Agriculture activity (ref: no) Yes, same side 2.10 (1.07–4.11) 0.031 2.15 (1.11–4.17) 0.024
Yes, other side 2.07 (1.15–3.71) 0.015 2.21 (1.25–3.90) 0.006
Previous AH treatment (ref: yes) No 1.77 (1.13–2.77) 0.012 1.82 (1.16–2.87) 0.010
na 2.10 (0.89–4.96) 0.090 2.05 (0.84–4.94) 0.111
Population density (ref: low) Intermediate 0.99 (0.57–1.71) 0.969
High 1.31 (0.77–2.25) 0.322
na 1.51 (0.59–3.87) 0.387
Distance to Nsitim River (ref: > 400 m) 300–400 m 1.40 (0.84–2.34) 0.198 1.41 (0.89–2.21) 0.140
0–300 m 2.44 (0.99–6.01) 0.052 2.78 (1.14–6.74) 0.024
Distance to Kwilu River (ref: > 400 m) 300–400 m 0.64 (0.32–1.30) 0.216
0–300 m 1.23 (0.64–2.36) 0.543
Number of household members 1.04 (0.93–1.18) 0.475
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forest. The local population goes to this small river for 
bathing, for washing clothes and for collecting drinking 
water. The access to the Nsitim is swampy and no crops 
are grown in this area. Thus, this environment may be 
favorable for specific Anopheles species such as A. mou-
cheti (s.l.) or A. nili (s.l.) that breed in slow-flowing riv-
ers [23, 24]. Further entomological studies are needed to 
identify LF vectors in Central Africa.
It was also interesting that staying overnight in the 
bush was a risk factor for mf. It is likely that this activ-
ity increases exposure to mosquitoes. This risk factor 
was also identified in our prior study in the Repub-
lic of Congo [5]. People who acquire filarial infections 
in the bush may constitute an important reservoir for 
secondary transmission inside the village. These results 
from two studies in different countries suggest that syl-
vatic or peri-sylvatic exposure to mosquitoes is impor-
tant for LF transmission in Central Africa [5]. More 
work is needed to compare vector species and densities 
in villages and forested bush areas in LF endemic areas 
in this region.
Conclusions
This study has provided useful information on the epide-
miology of LF in Central Africa. Age, sex, environment, 
and individual behavior were important risk factors for 
infection, and these findings were consistent with those 
Table 4 Population attributable fractions associated with the significant independent variables for filarial antigenaemia and 
microfilaraemia
Abbreviation: AH, anthelmintic drug; CI, confidence interval
Variable Antigenaemia Microfilaraemia
Population attributable 
fraction
95% CI P Population attributable 
fraction
95% CI P
Males 12.7 3.7–20.9 0.006 21.7 3.6–36.4 0.021
No bednet 9.4 1.8–16.3 0.016 – – –
No previous AH treatment 25.7 8.9–39.4 0.004 43.3 12.0–63.5 0.011
Occasional stay in the bush 5.5 0.1–11.3 0.078 17.0 2.8–29.1 0.020
Agricultural activity 30.5 7.4–47.9 0.013 – – –
Distance to Nsitim < 400 m 9.4 0.8–17.3 0.034 20.7 2.7–35.3 0.027
Table 5 Multivariable logistic regression analysis of risk factors for filarial antigenaemia and microfilaraemia in the total population
a As only one individual had taken pyrantel, the models were performed on 819 individuals (the subject having taken pyrantel was considered as missing data)
b Adjusted on age, sex, latrine, bednets, village, occasional overnight stay in the bush, agricultural activity, fishing, distance to the Nsitim and Kwilu rivers, population 
density and number of household members
c Adjusted on age, sex, occasional overnight stay in the bush, bednets, distance to the Nsitim and Kwilu rivers, and agricultural activity
d Adjusted on age, sex, occasional overnight stay in the bush, and distance to the Nsitim River
Abbreviations: Adj OR, adjusted odds ratio; AH, anthelmintic drug; CI, confidence interval; LR, likelihood ratio
Variable Category Antigenaemia  modela Microfilaraemia  modela
Full model Final model Full model Final model
Adj OR (95% CI)b P Adj OR (95% CI)c P Adj OR (95% CI)b P Adj OR (95% CI)d P
Previous AH treatment Levamisole (n = 117) 0.41 (0.22–0.76) 0.005 0.40 (0.21–0.76) 0.005 0.40 (0.16–0.98) 0.046 0.41 (0.17–0.99) 0.048
(ref: no) Mebendazole (n = 53) 0.75 (0.35–1.61) 0.460 0.77 (0.35–1.69) 0.509 0.52 (0.17–1.52) 0.237 0.56 (0.19–1.64) 0.291
Albendazole (n = 52) 0.79 (0.37–1.65) 0.525 0.73 (0.34–1.55) 0.414 0.36 (0.10–1.29) 0.115 0.35 (0.10–1.24) 0.104
LR test random effect 0.065 0.005 0.252 0.197
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recently reported from a study in the Republic of Congo. 
Additional studies with strong entomology components 
should be conducted to further define the epidemiol-
ogy and explain the highly focal distribution of LF in this 
important region.
Abbreviations
GPELF: Global Programme to Eliminate Lymphatic Filariasis; MDA: mass drug 
administration; LF: lymphatic filariasis; IVM: ivermectin; ALB: albendazole; 
NTD: neglected tropical disease; FTS: filariasis test strip; CFA: circulating filarial 
antigens; mf: microfilariae; DOLF: Death to Onchocerciasis and Lymphatic 
Filariasis.
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